Mometasone nasal spray
Generic name
Mometasone nasal spray
Brand name
ATC Code
R01AD09
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Allergic rhinitis |
|---|
|
Renal impaiment in children > 3 months
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
Growth retardation, psychological effects (behavioural).
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
Growth retardation: If long-term chronic use of nasal corticosteroids in children is necessary, give as low a dose as possible. Growth retardation in children has been reported with use of therapeutic doses of nasal corticosteroids; monitor height regularly with long-term use, especially with combined inhalation therapy for asthma. If growth inhibition occurs, try to reduce dosage and refer to pediatrician.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Sympathomimetics, plain | ||
|---|---|---|
| R01AA08 | ||
| R01AA05 | ||
| R01AA09 | ||
| R01AA07 | ||
| Sympathomimetics, combinations excl. corticosteroids | ||
|---|---|---|
| R01AB01 | ||
| Antiallergic agents, excl. corticosteroids | ||
|---|---|---|
| R01AC03 | ||
| R01AC01 | ||
| R01AC02 | ||
| Corticosteroids | ||
|---|---|---|
| R01AD58 | ||
| R01AD01 | ||
| R01AD05 | ||
| R01AD08 | ||
| R01AD12 | ||
| R01AD12 | ||
| R01AD59 | ||
| R01AD11 | ||
| Other nasal preparations | ||
|---|---|---|
| R01AX10 | ||
| OTHER NASAL PREPARATIONS | ||
|---|---|---|
| R01AX10 | ||
References
- Schering Plough BV, SPC Nasonex (RVG 21613) 13-03-2020, www.geneesmiddeleninformatiebank.nl
- UpToDate®, UpToDate®, Pediatric Drug information: Mometasone Lexicomp® Topic 9778 Version 155.0, accessed 09/2018
- Galenpharma, SmPC MomeAllerg 50 µg/Sprühstoß Nasenspray Suspension (91322.00.00), 09/2014
- MSD, SmPC Nasonex 50 µg/Sprühstoß Nasenspray Suspension (40803.00.00), 12/2017
Changes
Therapeutic Drug Monitoring
Overdose
